Annual Retained Earnings
-$1.66 B
-$481.19 M-40.88%
December 31, 2023
Summary
- As of February 8, 2025, NTLA annual retained earnings is -$1.66 billion, with the most recent change of -$481.19 million (-40.88%) on December 31, 2023.
- During the last 3 years, NTLA annual retained earnings has fallen by -$1.22 billion (-281.14%).
- NTLA annual retained earnings is now -17285.25% below its all-time high of -$9.54 million, reached on December 31, 2014.
Performance
NTLA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$2.05 B
-$135.71 M-7.09%
September 30, 2024
Summary
- As of February 8, 2025, NTLA quarterly retained earnings is -$2.05 billion, with the most recent change of -$135.71 million (-7.09%) on September 30, 2024.
- Over the past year, NTLA quarterly retained earnings has dropped by -$522.28 million (-34.22%).
- NTLA quarterly retained earnings is now -9238.54% below its all-time high of -$21.94 million, reached on December 31, 2015.
Performance
NTLA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
NTLA Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -40.9% | -34.2% |
| 3 y3 years | -281.1% | -229.5% |
| 5 y5 years | -725.0% | -651.5% |
NTLA Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -135.9% | at low | -191.4% | at low |
| 5 y | 5-year | -451.2% | at low | -580.8% | at low |
| alltime | all time | <-9999.0% | at low | -9238.5% | at low |
Intellia Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$2.05 B(+7.1%) |
| Jun 2024 | - | -$1.91 B(+8.3%) |
| Mar 2024 | - | -$1.77 B(+6.5%) |
| Dec 2023 | -$1.66 B(+40.9%) | -$1.66 B(+8.7%) |
| Sep 2023 | - | -$1.53 B(+8.7%) |
| Jun 2023 | - | -$1.40 B(+9.7%) |
| Mar 2023 | - | -$1.28 B(+8.8%) |
| Dec 2022 | -$1.18 B(+67.5%) | -$1.18 B(+10.7%) |
| Sep 2022 | - | -$1.06 B(+11.9%) |
| Jun 2022 | - | -$950.55 M(+11.8%) |
| Mar 2022 | - | -$849.87 M(+20.9%) |
| Dec 2021 | -$703.00 M(+61.6%) | -$703.00 M(+13.1%) |
| Sep 2021 | - | -$621.76 M(+13.0%) |
| Jun 2021 | - | -$550.12 M(+14.3%) |
| Mar 2021 | - | -$481.31 M(+10.6%) |
| Dec 2020 | -$435.11 M | -$435.11 M(+10.7%) |
| Sep 2020 | - | -$392.92 M(+7.6%) |
| Jun 2020 | - | -$365.08 M(+9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$332.68 M(+10.6%) |
| Dec 2019 | -$300.88 M(+49.7%) | -$300.88 M(+10.4%) |
| Sep 2019 | - | -$272.60 M(+9.5%) |
| Jun 2019 | - | -$248.97 M(+11.5%) |
| Mar 2019 | - | -$223.28 M(+11.1%) |
| Dec 2018 | -$201.03 M(+66.0%) | -$201.03 M(+10.5%) |
| Sep 2018 | - | -$181.96 M(+14.3%) |
| Jun 2018 | - | -$159.26 M(+16.2%) |
| Mar 2018 | - | -$137.04 M(+13.1%) |
| Dec 2017 | -$121.11 M(+126.1%) | -$121.11 M(+24.7%) |
| Sep 2017 | - | -$97.15 M(+18.8%) |
| Jun 2017 | - | -$81.79 M(+23.6%) |
| Mar 2017 | - | -$66.20 M(+23.6%) |
| Dec 2016 | -$53.57 M(+144.2%) | -$53.57 M(+24.6%) |
| Sep 2016 | - | -$43.01 M(+21.1%) |
| Jun 2016 | - | -$35.52 M(+24.1%) |
| Mar 2016 | - | -$28.63 M(+30.5%) |
| Dec 2015 | -$21.94 M(+130.0%) | -$21.94 M |
| Dec 2014 | -$9.54 M | - |
FAQ
- What is Intellia Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Intellia Therapeutics?
- What is Intellia Therapeutics annual retained earnings year-on-year change?
- What is Intellia Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly retained earnings year-on-year change?
What is Intellia Therapeutics annual retained earnings?
The current annual retained earnings of NTLA is -$1.66 B
What is the all time high annual retained earnings for Intellia Therapeutics?
Intellia Therapeutics all-time high annual retained earnings is -$9.54 M
What is Intellia Therapeutics annual retained earnings year-on-year change?
Over the past year, NTLA annual retained earnings has changed by -$481.19 M (-40.88%)
What is Intellia Therapeutics quarterly retained earnings?
The current quarterly retained earnings of NTLA is -$2.05 B
What is the all time high quarterly retained earnings for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly retained earnings is -$21.94 M
What is Intellia Therapeutics quarterly retained earnings year-on-year change?
Over the past year, NTLA quarterly retained earnings has changed by -$522.28 M (-34.22%)